Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Concurrent Disorders”

1,738 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,738 results

Not applicableActive Not RecruitingNCT06755164
What this trial is testing

Effects of Combined Aerobic and Cognitive Training in a Simultaneous or Sequential Paradigm on Cognition and Brain Functional Activity in Patients with AMCI

Who this might be right for
Mild Cognitive Impairment (MCI)AMCI - Amnestic Mild Cognitive ImpairmentNeurodegenerative Dementia+1 more
IRCCS San Raffaele 55
Large-scale testing (Phase 3)Study completedNCT01097252
What this trial is testing

Weekly Versus Three-week Chemoradiation in Patients With Advanced Cervical Cancer

Who this might be right for
Cervical Cancers
Korea Cancer Center Hospital 104
Not applicableNot Yet RecruitingNCT06060847
What this trial is testing

Liver Resection and Simultaneous Sleeve Gastrectomy for MS-HCC (LIRESS)

Who this might be right for
Carcinoma, HepatocellularMetabolic Syndrome
Ospedale V. Fazzi 50
Not applicableEnded earlyNCT01419587
What this trial is testing

Ketogenic Diet With Chemoradiation for Lung Cancer (KETOLUNG)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
University of Iowa 11
Not applicableStudy completedNCT05232955
What this trial is testing

Investigations of the Pathophysiology of Gilles de la Tourette Syndrome. Part 1: Simultaneous PET and 3T MRI

Who this might be right for
Gilles de la Tourette SyndromeTourette Syndrome
Max Planck Institute for Human Cognitive and Brain Sciences 40
Testing effectiveness (Phase 2)WithdrawnNCT03991104
What this trial is testing

SOX-based CRT for Esophageal Cancer.

Who this might be right for
Esophageal Cancer
Zhejiang Provincial People's Hospital
Not applicableStudy completedNCT02454647
What this trial is testing

Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients

Who this might be right for
Gastric CancerAdenocarcinomaEffects of Chemotherapy+2 more
Clinica Universidad de Navarra, Universidad de Navarra 46
Testing effectiveness (Phase 2)Looking for participantsNCT07699185
What this trial is testing

Neoadjuvant Cardonilizumab Combined With Neoadjuvant Chemoradiotherapy Can Resect Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Tongji Hospital 336
Not applicableLooking for participantsNCT04383808
What this trial is testing

Clinical Translation of a Novel Brain PET Insert for Simultaneous PET/MR

Who this might be right for
Brain Disease
Stanford University 40
Testing effectiveness (Phase 2)Study completedNCT00003158
What this trial is testing

S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 96
Not applicableStudy completedNCT03279640
What this trial is testing

Effects of Brain Network by Simultaneous Dual-mode Stimulation in Subacute Stroke Patients

Who this might be right for
StrokeMotor Disorder
Samsung Medical Center 24
Testing effectiveness (Phase 2)Ended earlyNCT03050060
What this trial is testing

Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer

Who this might be right for
Metastatic Kidney CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Cutaneous Melanoma AJCC v6 and v7+2 more
University of Washington 21
Testing effectiveness (Phase 2)Ended earlyNCT00417248
What this trial is testing

Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Nasser Hanna, M.D. 8
Not applicableUnknownNCT03912155
What this trial is testing

Multi-scale Analysis of Physiological Brain Networks

Who this might be right for
Epilepsy
Assistance Publique Hopitaux De Marseille 240
Not applicableLooking for participantsNCT04409860
What this trial is testing

The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Chongqing University Cancer Hospital 120
Testing effectiveness (Phase 2)Study completedNCT00055835
What this trial is testing

S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium

Who this might be right for
Bladder CancerUrethral Cancer
SWOG Cancer Research Network 7
Testing effectiveness (Phase 2)Study completedNCT00412425
What this trial is testing

Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 30
Not applicableStudy completedNCT01023048
What this trial is testing

Concurrent Single Gene and 24 Chromosome Aneuploidy Preimplantation Genetic Diagnosis (PGD)

Who this might be right for
Any Single Gene Disorder (Cystic Fibrosis, Tay-Sachs)
Natera, Inc. 56
Not applicableStudy completedNCT06376825
What this trial is testing

The Efficacy and Acceptability of an Internet-Based Self-Help Program to Reduce Burnout

Who this might be right for
Burnout, Professional
Ahmet Nalbant 25
Testing effectiveness (Phase 2)Study completedNCT00815308
What this trial is testing

Erbitux Combined With Chemo-radiotherapy in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Shandong Cancer Hospital and Institute 55
Next Page